The IES Diagnostics, bio-clinical diagnostics laboratory located in the Technological Park of Bizkaia, offers a differential model of user care, grounded on innovation and experience.
The IES Diagnostics project, spin-off of the Basque company of the innovative healthcare supplier IES Medical, arises in the midst of the pandemic from the need to advance in the application of new bio-clinical diagnostic discoveries theerby making them accessible to all citizens.
Thus, under this premise, it has developed a service model that combines the availability of high-impact diagnostic tests, with a system that facilitates user experience and results comprehension.
Herein we find the first ground-breaking aspect offered by IES Diagnostics: the user does not have to travel to perform the analytics, rather the diagnostic test selected kit is sent to their home. To achieve this, it uses a novel device that allows the required volume of plasma to be collected with a minimum puncture on the fingertip. The laboratory is responsible for both the delivery and collection of the sample.
The Basque laboratory is at the forefront in the use of VAMS (Volumetric Absorption MicroSampling) technology, which collects dry blood. The device used ensures maximum stability of the sample for several weeks at room temperature. Alongside offering a painless system for the user, all risk of spillage and contamination is eliminated, making it the optimal device for home testing.
Once in the laboratory, the samples are processed on a robotic processing platform unique in Spain, fully automated, which provides superior precision with minimal manual operation.
Finally, a bio-report is issued, which the patient can access through a web platform created for this purpose. This report is another distinctive value of the service offered by IES Diagnostics: the information is displayed in a highly graphic and easily understandable manner, with tailor made comment of the physician so that the user can make pertinent decisions.
The inaugural test of its portfolio is the measurement of neutralising antibodies against Covid, the only test on the market that allows quantifying the level of immune protection in specific numbers of neutralising antibodies, which are the ones that truly prevent the progression of the infection. Currently, it is diversifying towards other diseases, such as digestive disorders (food intolerances, microbiota studies, amongst others) and studying new areas of interest for people. And among its future plans is to continue collaborating with local agents, with a view to expanding its offer as to continue to develop as a company.
IES Diagnostics, it must be said, has been made possible thanks to the support of Basque institutions such as the Provincial Council of Bizkaia and Beaz through the 2i Plan to Foster Innovation and Advanced Investment 2021. It is also a member of the Basque Health Cluster along with the more than 90 key companies and institutions in the bio sector of the Basque Country to promote biotechnological growth. Furthermore, it has always enjoyed the backing of BIC Bizkaia, in the Bizkaia Technology Park.